The ROE as of December 2024 (TTM) for AN2 Therapeutics, Inc. (ANTX) is -57.63%

According to AN2 Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -57.63%. This represents a change of 298.85% compared to the average of -14.45% of the last 4 quarters.

AN2 Therapeutics, Inc. (ANTX) Historical ROE (quarterly & annually)

How has ANTX ROE performed in the past?

The mean historical ROE of AN2 Therapeutics, Inc. over the last ten years is -20.05%. The current -57.63% ROE has changed 187.42% with respect to the historical average. Over the past ten years (40 quarters), ANTX's ROE was at its highest in in the December 2021 quarter at 15.91%. The ROE was at its lowest in in the March 2021 quarter at -74.45%.

AN2 Therapeutics, Inc. (ANTX) ROE by Quarter and Year

Discovering the peaks and valleys of AN2 Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AN2 Therapeutics, Inc. (ANTX) Average ROE

How has ANTX ROE performed in the past?

The current ROE of AN2 Therapeutics, Inc. (ANTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

AN2 Therapeutics, Inc. (ANTX) ROE vs. Peers

How is ANTX’s ROE compared to its peers?

AN2 Therapeutics, Inc.’s ROE is greater than Aerovate Therapeutics, Inc. (-90.19%), greater than Adagene Inc. (-50.10%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.95%), greater than Rezolute, Inc. (-69.83%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), greater than Mineralys Therapeutics, Inc. (-55.92%), greater than Molecular Partners AG (-39.16%), greater than Pharvaris N.V. (-38.27%), greater than PepGen Inc. (-60.17%), greater than PMV Pharmaceuticals, Inc. (-24.20%), less than Eliem Therapeutics, Inc. (0%), greater than MediciNova, Inc. (-20.70%),

Build a custom stock screener for AN2 Therapeutics, Inc. (ANTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AN2 Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AN2 Therapeutics, Inc. (ANTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AN2 Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.